Results 61 to 70 of about 3,282 (184)

PCN48 IMPACT ON HOSPITAL OUTPATIENT VISIT COSTS BY INITIATING PALONOSETRON VERSUS OTHER 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONISTS FOR PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) AMONG PATIENTS WITH CANCER [PDF]

, 2011
Christopher Craver, J. Gayle, S Balu, David A. Buchner   +3 more
openalex   +1 more source

Multicenter phase IV study of palonosetron in the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with non-Hodgkin lymphomas undergoing repeated cycles of moderately emetogenic chemotherapy

, 2013
Brian S. Choi, Gabriela Borsaru, Gianluca Ballinari, Daniel L. Voisin, Nicola Di Renzo   +4 more
openalex   +2 more sources

One-Day Versus Three-Day Dexamethasone in Combination with Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Individual Patient Data-Based Meta-Analysis [PDF]

, 2019
Yuki Okada, Koji Oba, Naoto Furukawa, Yoshimasa Kosaka, Kenji Okita, Satoshi Yuki, Yoshito Komatsu, Luigi Celio, Matti Aapro   +8 more
openalex   +1 more source

Netupitant / palonosetron with dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous hematopoietic stem cell transplantation: a single-center experience

Онкогематология
Aim. To assess efficacy of netupitant / palonosetron with dexamethasone for chemotherapy‑induced nausea and vomiting in 20 patients with multiple myeloma who underwent autologous hematopoietic stem cell transplantation.   Materials and methods.
N. E Mochkin, N. S. Shorokhov, V. O. Sarzhevskiy, V. S. Bogatyrev, A. A. Samoylova, A. A. Rukavitsyn, E. G. Smirnova, A. E. Bannikova, A. A. Mamedova, Yu. V. Protopopova, V. Ya. Melnichenko   +10 more
doaj   +1 more source

Management of postoperative nausea and vomiting: focus on palonosetron

, 2008
Michael Paech, Muchatuta
openalex   +2 more sources

Application of Box-Behnken design for optimization of an RP-HPLC method for determination of palonosetron and netupitant in their combined dosage form in presence of their impurities

, 2023
Mohamed A. ElHamid, Ehab F. Elkady, Eman A. Mostafa   +2 more
openalex   +1 more source

Prevention of acute chemotherapy-induced nausea and vomiting: the role of palonosetron

Cancer Management and Research, 2009
Emilio Bajetta, Sara Pusceddu, Valentina Guadalupi, Monika Ducceschi, Luigi CelioMedical Oncology Unit 2, Fondazione IRCCS “Istituto Nazionale dei Tumori”, Milan, ItalyAbstract: Prevention of nausea and vomiting is the main goal of ...
Emilio Bajetta, Sara Pusceddu, Valentina Guadalupi, et al   +3 more
doaj  

PCN5 EFFICACY OF PALONOSETRON (PAL) COMPARED TO OTHER SEROTONIN INHIBITORS (5-HT3R) IN PREVENTING CHEMOTHERAPYINDUCED NAUSEA AND VOMITING (CINV) IN PATIENTS RECEIVING MODERATELY OR HIGHLY EMETOGENIC (MOHE) TREATMENT: AN UPDATE OF THE PREVIOUSLY PUBLISHED SYSTEMATIC REVIEW AND META-ANALYSIS

, 2010
T.E.A. Botrel, O Clark, LGO Clark, Ludovica Paladini, E Faleiros, B Pegoretti   +5 more
openalex   +1 more source

A comparative study of palonosetron versus palonosetron and dexamethasone for the prevention of postoperative nausea and vomiting in subjects undergoing laparoscopic surgeries: A randomized double-blind control study

, 2016
Aastha Srivastava, KPai Raghavendra, LeenaHarshad Parate   +2 more
openalex   +1 more source

Effects of palonosetron on prolongation of corrected QT intervals may be less than reliable [PDF]

, 2014
Jeounghyuk Lee, Junyong In
openalex   +1 more source